Neuropsychopharmacology Grants

Integrative Behavioral Neuroscience Award

The American College of Neuropsychopharmacology (ACNP) announces the creation of a prize in integrative behavioral neuroscience. This prize is being established to stimulate the genesis of solutions to a major practical and conceptual barrier to improved understanding of mental illnesses - the absence of models that successfully integrate wide-ranging molecular and neural substrates of these illnesses. Such models will require computational and bioinformatics strategies that integrate data across multiple data bases, determine the relative regulatory strengths of individual components of feed-forward and feedback signaling systems, and permit the prediction of specified behavioral outcomes. We welcome scientists from a wide range of disciplines to compete for this $35,000 prize, to be awarded at the ACNP Presidential Plenary session on December 6, 2010 at the Fontainebleau Miami Beach. The prize will be awarded for a paper that is judged by a panel of experts to represent a major step forward in the successful development of innovative bioinformatics strategies for integrating neurobiological data in the service of modeling psychiatric illness. The ACNP reserves the right to decline to award the prize if no submitted paper meets the intended goal. Papers may be submitted for consideration by email to acnp@acnp.org no later than October 15, 2010. Please indicate in the email subject line that the attached paper is in response to this announcement.

American College of Neuropsychopharmacology
545 Mainstream Drive Suite 110
Nashville TN 37228

Phone: (615) 324-2360
Fax: (615) 324-2361

E-Mail: acnp@acnp.org

P.B. Dews Lifetime Achievement Award for Research in Behavioral Pharmacology

Deadline for submission of nominations is September 15, 2011

ASPET’s Division of Behavioral Pharmacology sponsors the P. B. Dews Award for Research in Behavioral Pharmacology to recognize outstanding lifetime achievements in research, teaching and professional service in the field of Behavioral Pharmacology and to honor Peter Dews for his seminal contributions to the development of behavioral pharmacology as a discipline. The biennial award is supported by an endowment made possible by contributions from Aventis, Centre de Recherche Pierre Fabre, Eli Lilly, Harvard University, International Life Sciences Institute Caffeine Committee, Merck (San Diego), Pepsi Cola Company, Pfizer Central Research and Pfizer Global Research and Development, Pharmacia, Wyeth Research, and ASPET members. Contributions to the endowment fund are also welcome.

The Award consists of $750, a plaque, and partial travel expenses to the award ceremony at the ASPET annual meeting. The recipient will be invited by the Chair of the Division of Behavioral Pharmacology to deliver a special lecture on this occasion. The lecture will be published subsequently in an appropriate ASPET-sponsored publication. The awardee in 2008 was Dr. Charles Schuster , from Wayne State University.

There are no restrictions on nominees for this award. Nominations may be made by members of ASPET or of any relevant scientific society. Selection will be made by the P.B. Dews Award Committee, appointed by the President of ASPET with input from the Division for Behavioral Pharmacology.

Nominations shall be submitted electronically to jane.nelson@aspet.org and shall consist of:

Description of the candidate’s major contributions, including scientific, teaching and professional achievements.
Candidate’s curriculum vitae and bibliography.
List of the candidate’s trainees.
Brief biographical sketch of the candidate.
Five major publications (provided as PDFs or as hyperlinks to the article). Submit each manuscript PDF as a separate attachment.